Detection of Recombinant Proteins SOX2 and OCT4 Interacting in HEK293T Cells Using Real-Time Quantitative PCR
Kanayev D. Abilmazhenova D. Akhmetollayev I. Sekenova A. Ogay V. Kulyyassov A.
January 2023MDPI
Life
2023#13Issue 1
In vivo biotinylation using wild-type and mutants of biotin ligases is now widely applied for the study of cellular proteomes. The commercial availability of kits for the highly efficient purification of biotinylated proteins and their excellent compatibility with LC-MS/MS protocols are the main reasons for the choice of biotin ligases. Since they are all enzymes, however, just a very low expression in cells is required for experiments. Therefore, it can be difficult to perform the quantifications of these enzymes in various samples. Traditional methods, such as western blotting, are not always fit for the detection of the expression levels. Therefore, real-time qRT-PCR, a technology that is more sensitive, was used in this study to quantify the expression of BirA fusions. Using this method, we detected high expression levels of BirA fusions in models of interactions of pluripotency transcription factors to carry out their relative quantification. We also found the absence of the competing endogenous proteins SOX2 and OCT4, as well as no cross-reactivity between BAP/BirA and the endogenous biotinylation system in HEK293T cells. Thus, these data indicated that the high level of biotinylation is due to the in vivo interaction of BAP-X and BirA-Y (X,Y = SOX2, OCT4) in the cell rather than their random collision, a big difference in the expression level of BirA fusions across samples or endogenous biotinylation.
Biotin Acceptor Peptide (BAP) , biotin ligases , liquid chromatography tandem mass-spectrometry (LC-MS/MS) , Proximity Utilizing Biotinylation (PUB) , reverse transcription polymerase chain reaction (RT-PCR) , transcription factors of pluripotency , western blotting
Text of the article Перейти на текст статьи
Limited Liability Partnership “National Center for Biotechnology” Ministry of Healthcare of the Republic of Kazakhstan, 3/5, Kurgalzhynskoye Road, Astana, 010000, Kazakhstan
Limited Liability Partnership “National Center for Biotechnology” Ministry of Healthcare of the Republic of Kazakhstan
10 лет помогаем публиковать статьи Международный издатель
Книга Публикация научной статьи Волощук 2026 Book Publication of a scientific article 2026